2019-09-16 08:10 |
Detaljnije - Slični zapisi
|
2019-03-15 16:24 |
Imaging of iron metabolism
Iron is an essential and critical trace metal in the human body as it is involved in many vital processes like oxygen transport and redox reactions. However, excess iron is toxic and can cause oxidative stress (Dev, 2017). [...]
MED-023.-
Geneva : CERN, 2019 - 2.
Fulltext: PDF;
|
Detaljnije - Slični zapisi
|
2019-03-15 16:05 |
Detaljnije - Slični zapisi
|
2019-03-12 18:16 |
Detaljnije - Slični zapisi
|
2019-03-12 11:47 |
Detaljnije - Slični zapisi
|
2019-03-07 15:20 |
No-carrier-added 175Yb production at MEDICIS from external ILL target
Introduction & background: (state of the art and goal/motivation for the project) High-energy β- emitter 90Y(T1/2 :64 h ; Eβmean = 934 keV) and medium energy β- emitter 177Lu (T1/2: 6.73 d ; Eβ-mean = 154 keV) are the most widely used radionuclides for therapeutic radiopharmaceuticals. Monte Carlo simulations have shown that 177Lu might be more appropriate than 90Y for the treatment of minimal residual disease [1] and practical experience in clinics have proven the favorable properties of 177Lu regarding the significant reduction of undesired side effects to healthy organs (e.g [...]
MED-019.-
Geneva : CERN, 2019 - 2.
Fulltext: PDF;
|
Detaljnije - Slični zapisi
|
2019-03-07 15:16 |
No-carrier-added 169Er production at MEDICIS from target irradiated at ILL
Introduction & background: (state of the art and goal/motivation for the project) To date, 169Er (carrier-added) is used for the treatment of chronic rheumatoid arthritis in order to eliminate diseased synovium through irradiation and to improve joint function [1, 2]. However, its decay properties (T1/2 = 9.4 d, Eβmean = 219 keV) are very promising for radionuclide therapy of metastasized cancer diseases. [...]
MED-018.-
Geneva : CERN, 2019 - 2.
Fulltext: PDF;
|
Detaljnije - Slični zapisi
|
2019-03-07 15:13 |
167Tm production at MEDICIS from external PSI target
Introduction & background: (state of the art and goal/motivation for the project) 167Tm (T1/2 = 9.25 d) is a potential radionuclide both for medical diagnostics and therapy due to its gamma (Eγ = 207.8 keV, I = 42%), and conversion/Auger electron emission (ECE/AE = 5-100 keV, I = 120%) [1]. Previously, 167Tm-citrate was used for tumor imaging using its 207 keV γ-line [2] [...]
MED-017.-
Geneva : CERN, 2019 - 2.
Fulltext: PDF;
|
Detaljnije - Slični zapisi
|
2018-09-24 18:32 |
Theranostic radiolabeled nanoparticles for ovarian cancer by folate receptor targeting
Patients with epithelial ovarian cancer (EOC) are frequently diagnosed at stage III/IV with widespread peritoneal carcinomatosis, and have a poor overall survival [1]. Because of current screening techniques do not provide early diagnoses of small volume disease, new methods that enhance the detection and treatment of EOC are needed to improve the prognosis of this type of patients. [...]
MED-016.-
Geneva : CERN, 2018 - 3.
Fulltext: PDF;
|
Detaljnije - Slični zapisi
|
2018-09-24 18:24 |
Detaljnije - Slični zapisi
|